Does acquired angioedema increase the risk of surgery with cardiopulmonary bypass?  by Donatelli, Francesco et al.
trifugal pump. The left internal thoracic artery was grafted to
the left anterior descending artery, and two single saphenous
vein grafts were performed on the ramus intermedius and the
right posterior descending artery. Aortic crossclamp time and
CPB time were 43 and 57 minutes, respectively. A hollow-
fiber oxygenator was used. During the operation and the early
postoperative hours, administration of tranexamic acid (10
mg/kg bolus followed by 5 mg · kg–1 ·h–1 infusion for the first
12 hours) was the only prophylactic measure against acquired
angioedema. C1-INH was available but was not used.
Bleeding conditions were satisfactory (total, 490 mL), and the
patient was weaned from respiratory support 5 hours after the
operation with no respiratory complications before or after
extubation. The following postoperative course was unevent-
ful. The patient was discharged on the seventh postoperative
day. Oral medications included ticlopidine, 250 mg, and rani-
tidine, 300 mg. Measurement of complement components
throughout the procedure demonstrated a stable depletion of
the components of the classical pathway (C1q and C4) and of
its regulator (C1-INH) as expected in patients with acquired
angioedema. On the other hand, the levels of C3, the key com-
ponent of the system in which all complement-activating
pathways converge, showed a progressive decrease from a
preoperative level of 99% of normal value to a level of 73% at
the end of CPB.
Discussion. Acquired angioedema is characterized by defi-
ciency of C1-INH, resulting in continuous activation of the
classical complement pathway, leading to consumption of its
components, and impairing the regulation of the complement
and contact systems, coagulation, and fibrinolysis. Cardiac
operations requiring CPB in patients with acquired angioede-
ma are considered potentially at increased risk because of
complement activation related to contact of blood with artifi-
cial surfaces and may result in increased vascular permeabili-
ty, adult respiratory distress syndrome, and coagulopathy.
A successful case presented in recent years was performed
with adjunctive measures against potential complications relat-
ed to acquired angioedema, such as aprotinin administration4
and prophylactic infusion of C1-INH and antithrombin III.
Some aspects of surgical strategy must be stressed and may
have important implications:
1. Despite relatively young age and the absence of classi-
cal specific contraindications, bilateral internal thoracic
artery harvesting was avoided to minimize dissection of
tissues, surgical trauma, and potential bleeding sources.
Acquired angioedema is a rare condition characterized by the
deficiency of C1 inhibitor (C1-INH). This results in continuous
activation of the classical pathway, leading to consumption of
its components (C1, C2, and C4), and impairs the regulation of
the complement and contact systems, coagulation, and fibrinol-
ysis. Potentially lethal complications may ensue in such
patients, including laryngeal edema, acute abdominal syn-
dromes mimicking surgical emergencies, and hemorrhagic
diathesis.1-3 Cardiopulmonary bypass (CPB) determines com-
plement activation because of contact of blood with artificial
surfaces and may result in increased vascular permeability,
acute pulmonary failure resembling adult respiratory distress
syndrome, multiorgan failure, and bleeding disorders.2
Anecdotal reports regarding favorable2 or unfavorable3 out-
comes after cardiac surgery are reported in the literature in
patients with acquired angioedema, but the stratification of sur-
gical risk is difficult to assess because of the paucity of data.
Clinical summary.  A 62-year-old patient with a 7-year
history of acquired angioedema of autoimmune origin was
referred to our institution for the evaluation and treatment of
coronary artery disease. Recent history included inferior
myocardial infarction and postinfarction Canadian Cardio-
vascular Society class III angina pectoris despite adjusted
anti-ischemic medications. Cardiac catheterization and coro-
nary angiography revealed preserved ventricular function and
critical lesions of the left anterior descending artery, ramus
intermedius branch, and right coronary artery not amenable to
interventional cardiology techniques.
The patient was scheduled for surgery despite the presence
of acquired angioedema. Standard coronary artery bypass
grafting with extracorporeal circulation and cardioplegia was
performed in normothermic conditions with the use of a cen-
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2. A hollow-fiber oxygenator and a centrifugal pump were
selected to reduce complement activation, denaturation
of plasma proteins, and impairment of platelet function.
In fact, a case report concerning an unsuccessful opera-
tion3 relates to the use of a bubble oxygenator. The only
moderate consumption of C3, indicating activation of
the alternative pathway, did not cause side effects of
clinical relevance.
3. Normothemic CPB was performed to maintain more
physiologic conditions.
4. To overcome the possibility that massive protease acti-
vation in the absence of C1-INH could lead to activation
of the contact system causing complications, such as
bleeding, angioedema, or both, tranexamic acid was
administered intraoperatively. This antifibrinolytic
agent was proved to be effective in long-term prophy-
laxis of angioedema in patients with acquired angioede-
ma5 and has been used to prevent bleeding after CPB,
particularly since aprotinin became unavailable in
Europe.
5. Considering the satisfactory bleeding conditions at the
end of the operation, antithrombin III was not used.
In conclusion, cardiac operations with CPB are probably not
at high risk of complications related to acquired angioedema,
and adjunctive routine (ie, in the absence of specific complica-
tions, namely bleeding and respiratory failure related to
acquired angioedema) prophylactic measures may be reduced to
intraoperative antifibrinolytic therapy. However, definitive con-
clusions cannot be stated considering the low number of cases.
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